BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11843319)

  • 1. Ehlers-Danlos syndrome type IV with few extrathoracic findings: a newly recognized point mutation in the COL3A1 gene.
    Watanabe A; Kawabata Y; Okada O; Tanabe N; Kimura H; Hatamochi A; Shinkai H; Sakai N; Shimada T; Hiroshima K; Kuriyama T
    Eur Respir J; 2002 Jan; 19(1):195-8. PubMed ID: 11843319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene.
    Sadakata R; Hatamochi A; Kodama K; Kaga A; Yamaguchi T; Soma T; Usui Y; Nagata M; Ohtake A; Hagiwara K; Kanazawa M
    Intern Med; 2010; 49(16):1797-800. PubMed ID: 20720362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
    Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
    J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.
    Tsipouras P; Byers PH; Schwartz RC; Chu ML; Weil D; Pepe G; Cassidy SB; Ramirez F
    Hum Genet; 1986 Sep; 74(1):41-6. PubMed ID: 2875936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother and son with a COL3A1 mutation and a normal collagen III protein profile.
    Kroes HY; Pals G; van Essen AJ
    Clin Genet; 2003 Mar; 63(3):224-7. PubMed ID: 12694234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
    Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
    Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic analysis of three Korean patients with clinical features of Ehlers-Danlos syndrome type IV.
    Yang JH; Lee ST; Kim JA; Kim SH; Jang SY; Ki CS; Kim DK
    J Korean Med Sci; 2007 Aug; 22(4):698-705. PubMed ID: 17728513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the COL3A1 gene result in the Ehlers-Danlos syndrome type IV and alterations in the size and distribution of the major collagen fibrils of the dermis.
    Smith LT; Schwarze U; Goldstein J; Byers PH
    J Invest Dermatol; 1997 Mar; 108(3):241-7. PubMed ID: 9036918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehlers-Danlos syndrome type IV in association with a (c.970G>A) mutation in the COL3A1 gene.
    Rebelo M; Ramos L; Lima J; Vieira JD; Tavares P; Teixeira L; Matos A; Costa JN
    Acta Med Port; 2011; 24(6):1079-86. PubMed ID: 22713205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large kindred with Ehlers-Danlos syndrome type IV due to a point mutation (G571S) in the COL3A1 gene of type III procollagen: low risk of pregnancy complications and unexpected longevity in some affected relatives.
    Gilchrist D; Schwarze U; Shields K; MacLaren L; Bridge PJ; Byers PH
    Am J Med Genet; 1999 Feb; 82(4):305-11. PubMed ID: 10051163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel point mutation at donor splice-site in intron 42 of type III collagen gene resulting in the inclusion of 30 nucleotides into the mature mRNA in a case of vascular type of Ehlers-Danlos syndrome.
    Okita H; Ikeda Y; Mitsuhashi Y; Namikawa H; Kitamura Y; Hamasaki Y; Yamazaki S; Hatamochi A
    Arch Dermatol Res; 2010 Jul; 302(5):395-9. PubMed ID: 19543901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early venous manifestation of Ehlers-Danlos syndrome Type IV through a novel mutation in COL3A1.
    Wendorff H; Pelisek J; Zimmermann A; Mayer K; Seidel H; Weirich G; Hausser I; Siegel C; Zernecke A; Eckstein HH
    Cardiovasc Pathol; 2013; 22(6):488-92. PubMed ID: 23688910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-strand conformation polymorphism (SSCP) analysis of the COL3A1 gene detects a mutation that results in the substitution of glycine 1009 to valine and causes severe Ehlers-Danlos syndrome type IV.
    Nuytinck L; De Paepe A; Renard JP; Adriaens F; Leroy J
    Hum Mutat; 1994; 3(3):268-74. PubMed ID: 8019562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ehlers-Danlos Syndrome Type IV with Bilateral Pneumothorax.
    Nakagawa H; Wada H; Hajiro T; Nagao T; Ogawa E; Hatamochi A; Tanaka T; Nakano Y
    Intern Med; 2015; 54(24):3181-4. PubMed ID: 26666608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.
    Narcisi P; Richards AJ; Ferguson SD; Pope FM
    Hum Mol Genet; 1994 Sep; 3(9):1617-20. PubMed ID: 7833919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The substitution of glycine 661 by arginine in type III collagen produces mutant molecules with different thermal stabilities and causes Ehlers-Danlos syndrome type IV.
    Richards A; Narcisi P; Lloyd J; Ferguson C; Pope FM
    J Med Genet; 1993 Aug; 30(8):690-3. PubMed ID: 8411057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.